📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
146 analysed today
FollowTelegram
146
Today
152,008
All-time analysed
43,597
Positive
6,744
Negative
92,824
Neutral
8,775
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
848 announcements match the current filters (relevance ≥ 5).
BIL Vyapar Appoints Rachna Jhunjhunwala as Resolution Professional Under CIRP
BIL Vyapar Limited, formerly Binani Industries, has announced the appointment of Ms. Rachna Jhunjhunwala as the Resolution Professional (RP). This decision was finalized following the conclusion of e-voting by the Committee of Creditors (CoC) on December 26, 2025. The company has been under the Corporate Insolvency Resolution Process (CIRP) since November 13, 2025, following an NCLT order. The CoC also ratified expenses related to public announcements and the remuneration of the outgoing Interim Resolution Professional.
Key Highlights
Ms. Rachna Jhunjhunwala appointed as Resolution Professional (RP) following CoC e-voting concluded on Dec 26, 2025
Company entered Corporate Insolvency Resolution Process (CIRP) via NCLT order dated Nov 13, 2025
Committee of Creditors (CoC) ratified expenses for public announcements and IRP remuneration
The first meeting of the Committee of Creditors was held on Dec 19, 2025
👀 What to Watch
Investors should exercise extreme caution as equity value is often significantly diluted or wiped out during insolvency proceedings. Monitor the progress of the resolution plan to assess any potential recovery for stakeholders.
BIL Vyapar Appoints Rachna Jhunjhunwala as Resolution Professional Following CoC Meeting
BIL Vyapar Limited (formerly Binani Industries) has reported the outcome of its first Committee of Creditors (CoC) meeting held on December 19, 2025. The CoC has officially approved the appointment of Ms. Rachna Jhunjhunwala as the Resolution Professional (RP) to manage the company's insolvency process. Furthermore, the committee ratified the remuneration for the Interim Resolution Professional and approved expenses related to the insolvency proceedings initiated by the NCLT in November 2025.
Key Highlights
Ms. Rachna Jhunjhunwala appointed as Resolution Professional (RP) by the Committee of Creditors.
CoC ratified expenses for Public Announcement and other costs under the Insolvency and Bankruptcy Code 2016.
E-voting for the first CoC meeting concluded on December 26, 2025.
The company remains under Corporate Insolvency Resolution Process (CIRP) following a November 13, 2025, NCLT order.
👀 What to Watch
Investors should be aware that insolvency proceedings typically result in high risk for equity holders, often leading to total loss. Avoid new positions and monitor the resolution process for any potential restructuring plans.
BIL Vyapar Appoints Rachna Jhunjhunwala as Resolution Professional in 1st CoC Meeting
BIL Vyapar Limited, formerly Binani Industries, has progressed in its Corporate Insolvency Resolution Process (CIRP) following its first Committee of Creditors (CoC) meeting held on December 19, 2025. Through e-voting concluded on December 26, 2025, the CoC approved the appointment of Ms. Rachna Jhunjhunwala as the Resolution Professional (RP). The committee also ratified the remuneration of the Interim Resolution Professional and approved expenses incurred for public announcements under the Insolvency and Bankruptcy Code. The company has been under CIRP since the NCLT order dated November 13, 2025.
Key Highlights
Ms. Rachna Jhunjhunwala appointed as Resolution Professional (RP) following CoC e-voting on Dec 26, 2025
Company entered CIRP following an NCLT order dated Nov 13, 2025, with the order received on Nov 21, 2025
CoC ratified and approved expenses for public announcements and other IBC-related costs
Remuneration for the Interim Resolution Professional (IRP), Mr. Subodh Kumar Agrawal, was formally ratified
👀 What to Watch
Investors should exercise extreme caution as the company is in insolvency proceedings where equity holders typically face significant value erosion. Monitor for future updates regarding the submission and approval of any resolution plans.
BIL Vyapar Appoints Rachna Jhunjhunwala as Resolution Professional Under IBC Process
BIL Vyapar Limited, formerly Binani Industries, has concluded its first Committee of Creditors (CoC) meeting as part of its ongoing Corporate Insolvency Resolution Process (CIRP). The CoC approved the appointment of Ms. Rachna Jhunjhunwala as the Resolution Professional, succeeding the Interim Resolution Professional. The meeting also ratified the remuneration for the IRP and expenses related to the public announcement under the Insolvency and Bankruptcy Code 2016. The company has been under the management of insolvency professionals since the NCLT order on November 13, 2025.
Key Highlights
CoC approved the appointment of Ms. Rachna Jhunjhunwala as Resolution Professional on December 26, 2025.
Ratification of remuneration for Interim Resolution Professional Mr. Subodh Kumar Agrawal.
Approval of expenses related to the Public Announcement and other IBC-mandated costs.
The company entered CIRP following an NCLT order dated November 13, 2025, with the order received on November 21, 2025.
👀 What to Watch
Investors should exercise extreme caution as insolvency proceedings typically result in significant value erosion or total loss for equity shareholders. Monitor the resolution process for any potential restructuring plans that might impact the company's listing status.
BIL Vyapar Issues Revised Form G for CIRP; EOI Submission Deadline Feb 19, 2026
BIL Vyapar Limited, formerly known as Binani Industries, has issued a revised Form G inviting Expressions of Interest (EOI) under the Corporate Insolvency Resolution Process (CIRP). The company is currently in a distressed state, reporting zero operational revenue and only Rs. 2.51 lakh in other income for FY 2024-25. The insolvency process follows an NCLT order from November 2025, with the company currently having no employees. Prospective resolution applicants have until February 19, 2026, to submit EOIs, with final resolution plans expected by April 7, 2026.
Key Highlights
Last date for receipt of Expression of Interest (EOI) is February 19, 2026.
Final date for submission of Resolution Plans is set for April 7, 2026.
FY 2024-25 financials show zero revenue from operations and zero employees.
Company is under CIRP managed by Interim Resolution Professional Subodh Kumar Agrawal.
Provisional list of resolution applicants to be issued by February 26, 2026.
👀 What to Watch
Equity shareholders should exercise extreme caution as insolvency proceedings often result in total capital loss or delisting. It is advisable to monitor the resolution process for any updates on the company's future viability or liquidation.
BIL Vyapar Appoints Resolution Professional in First CoC Meeting Under IBC Process
BIL Vyapar Limited, formerly known as Binani Industries Limited, has concluded its first Committee of Creditors (CoC) meeting following its admission into the Corporate Insolvency Resolution Process (CIRP). The CoC approved the appointment of Ms. Rachna Jhunjhunwala as the Resolution Professional (RP), transitioning from the interim phase. The meeting, which concluded e-voting on December 26, 2025, also ratified expenses related to the public announcement and the remuneration of the Interim Resolution Professional. This follows the NCLT order dated November 13, 2025, which placed the company under insolvency proceedings.
Key Highlights
Appointment of Ms. Rachna Jhunjhunwala as Resolution Professional (RP) approved by the CoC.
Company entered Corporate Insolvency Resolution Process (CIRP) via NCLT order dated November 13, 2025.
E-voting for the first CoC meeting concluded on December 26, 2025, ratifying IRP remuneration and public announcement costs.
The company's affairs and assets are currently managed by the resolution professional under the IBC 2016 framework.
👀 What to Watch
Investors should be extremely cautious as equity shareholders typically face significant value erosion or total loss during insolvency proceedings. Monitor upcoming resolution plans to see if any value is preserved for minority shareholders.
BIL Vyapar CoC Approves Appointment of Resolution Professional Under Insolvency Process
BIL Vyapar Limited, formerly Binani Industries, announced that its first Committee of Creditors (CoC) meeting concluded on December 26, 2025. The CoC approved the appointment of Ms. Rachna Jhunjhunwala as the Resolution Professional (RP) to take over from the Interim Resolution Professional. Additionally, the committee ratified expenses related to the insolvency process and the IRP's remuneration. The company has been under the Corporate Insolvency Resolution Process (CIRP) since November 2025 following an NCLT order.
Key Highlights
CoC meeting held on Dec 19 and e-voting concluded on Dec 26, 2025, to approve key insolvency agendas.
Ms. Rachna Jhunjhunwala appointed as Resolution Professional (RP) for BIL Vyapar Limited.
Ratification of public announcement expenses and Interim Resolution Professional (IRP) remuneration.
The company remains under CIRP following the NCLT order passed on November 13, 2025.
👀 What to Watch
Equity shareholders should exercise extreme caution as insolvency proceedings often result in significant loss of value for existing shares. Monitor the resolution process for any potential restructuring plans that may impact the company's future.
Cantabil Q3 FY26 PAT Jumps 31% to ₹45.1 Cr; Revenue Up 19% YoY
Cantabil Retail India Limited reported a robust performance for Q3 FY26, with revenue growing 19% YoY to ₹264.4 crore and PAT increasing 31% to ₹45.1 crore. The company achieved a healthy 9-month same-store sales growth (SSG) of 6.3% and expanded its retail footprint to 646 stores across 8.82 lakh square feet. Management reaffirmed its 'Vision 2027' goal of reaching ₹1,000 crore in revenue by FY27, supported by GST rationalization benefits and consistent gross margins of 58-59%. The EBITDA margin for the quarter improved significantly to 36% from 32.6% in the previous year.
Key Highlights
Q3 FY26 PAT surged 31% YoY to ₹45.1 crore with EBITDA margins improving to 36%.
9-month FY26 revenue grew 20% to ₹599.1 crore, supported by a 6.3% same-store sales growth (SSG).
Total store network reached 646 outlets, with revenue per square foot for mature stores at ₹1,018 for the quarter.
Management targets ₹1,000 crore revenue by FY27 with sustainable gross margins of 58-59%.
Franchise stores now account for 131 outlets (20% of total), operating on a fixed commission model of 27-28%.
👀 What to Watch
Investors should note the strong margin expansion and consistent SSG as indicators of operational efficiency and brand strength. The clear roadmap to ₹1,000 crore revenue by FY27 suggests continued growth potential, making it a positive outlook for long-term holders.
Concord Biotech Q3 Revenue Up 14% to Rs 278 Cr; EBITDA Margins Impacted by Expansion Costs
Concord Biotech reported a 14% YoY revenue growth in Q3FY26, reaching Rs 278 crore, primarily driven by a 24% surge in the API segment. However, PAT declined by 16% YoY to Rs 64 crore due to commercialization expenses for the new injectable facility and setup costs for its US subsidiary, Stellon Biotech. EBITDA margins compressed to 35.6% from 40.1% a year ago, though normalized margins remain healthy at approximately 40%. The company achieved a significant milestone by receiving WHO-GMP certification for its injectable plant, paving the way for domestic market entry.
Key Highlights
Q3FY26 Revenue grew 14% YoY to Rs 278 crore, led by robust 24% growth in the API segment.
EBITDA margins stood at 35.6%, impacted by one-time setup costs; normalized margins are at ~40%.
Received WHO-GMP certification for Unit 4 (Injectable facility), enabling domestic brand launches.
Established US subsidiary Stellon Biotech Inc. to create a direct commercial footprint in the US market.
Appointed Raviraj Karia as the new Chief Financial Officer (CFO) with 23+ years of experience.
👀 What to Watch
Investors should monitor the ramp-up of the new injectable facility and the performance of the US subsidiary, as these are the primary drivers for future growth despite current margin pressure. The long-term outlook remains positive due to specialized fermentation capabilities and global expansion.
Panacea Biotec Q3 Results: Consolidated Net Profit at ₹389 Lakh; Standalone Loss Widens
Panacea Biotec reported a consolidated net profit of ₹389 lakh for the quarter ended December 31, 2025, a slight decline from ₹444 lakh in the previous year. Consolidated revenue from operations grew marginally to ₹16,519 lakh compared to ₹16,349 lakh YoY. However, the standalone business faced significant pressure, reporting a net loss of ₹736 lakh against a profit of ₹965 lakh in the same period last year. The company continues to benefit from exceptional income, including a ₹858 lakh settlement with Apotex Inc. and deferred consideration from previous brand sales.
Key Highlights
Consolidated revenue from operations increased 1.04% YoY to ₹16,519 lakh.
Formulations segment EBIT turned positive at ₹906 lakh compared to a loss of ₹758 lakh in Q3 FY25.
Vaccines segment reported a loss of ₹257 lakh at the EBIT level for the quarter.
Exceptional income of ₹1,679 lakh recognized in 9M FY26, including ₹858 lakh from a settlement with Apotex Inc.
Standalone net loss for 9M FY26 widened significantly to ₹2,970 lakh from ₹284 lakh in 9M FY25.
👀 What to Watch
Investors should exercise caution as the company remains loss-making on a 9-month consolidated basis despite the quarterly profit. Monitor the vaccines segment's recovery and the company's ability to generate consistent operational cash flow without relying on exceptional items.
Panacea Biotec Q3 FY26 Results: Consolidated Net Profit at ₹3.89 Cr; Revenue Grows 1% YoY
Panacea Biotec reported a consolidated net profit of ₹3.89 crore for Q3 FY26, a slight decline from ₹4.44 crore in the same quarter last year. Consolidated revenue from operations grew marginally by 1% YoY to ₹165.19 crore. For the nine-month period, the company remains in a net loss of ₹6.16 crore, though this narrowed from a loss of ₹6.73 crore in the previous year. The results were significantly supported by an exceptional income of ₹16.79 crore in the 9M period, including a settlement with Apotex Inc.
Key Highlights
Consolidated Q3 revenue reached ₹165.19 crore, a marginal 1% increase over the previous year's ₹163.49 crore.
Formulations segment profit improved significantly to ₹9.06 crore from a loss of ₹7.58 crore in Q3 FY25.
Vaccines segment reported a loss of ₹2.57 crore for the quarter despite revenue of ₹99.24 crore.
Exceptional income of ₹16.79 crore for 9M FY26 includes ₹8.58 crore from a settlement with Apotex Inc.
Standalone net loss stood at ₹7.36 crore for Q3 FY26, compared to a profit of ₹9.65 crore in Q3 FY25.
👀 What to Watch
Investors should monitor the company's ability to sustain operational profitability without relying on exceptional items and brand sale deferrals. While the turnaround in the formulations segment is positive, the core vaccine business remains under pressure.
Concord Biotech Approves Q3 FY26 Results; Appoints New Company Secretary
Concord Biotech's Board of Directors approved the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The statutory auditors, BSR & Co. LLP, issued a limited review report with an unmodified opinion, suggesting no major accounting concerns. Additionally, the company appointed Mr. Paritosh Trivedi as the new Company Secretary and Compliance Officer effective February 11, 2026. This appointment fills a key managerial personnel (KMP) role to oversee corporate governance and regulatory filings.
Key Highlights
Board approved unaudited financial results for the third quarter and nine months ended December 31, 2025.
Statutory auditors M/s. BSR & Co. LLP issued a Limited Review Report with an Unmodified Opinion.
Mr. Paritosh Trivedi appointed as Company Secretary, Compliance Officer, and Nodal Officer.
The new appointee brings 5 years of experience in corporate compliance across Textile, IT, and FMCG sectors.
The board meeting concluded at 6:22 P.M. on February 11, 2026.
👀 What to Watch
Investors should examine the detailed financial tables once published to assess revenue and margin performance for Q3. The appointment of a new compliance officer is a routine administrative update and does not impact the company's fundamental value.
Bhartiya International Q3 Net Profit Surges 183% YoY to ₹6.68 Crore
Bhartiya International Limited (BIL) reported a strong financial performance for the quarter ended December 31, 2025, with standalone revenue growing 33.5% YoY to ₹312.67 crore. The standalone net profit witnessed a massive jump of 183%, reaching ₹6.68 crore compared to ₹2.36 crore in the same quarter last year. For the nine-month period, the company has already surpassed its full-year FY25 profit, recording a net profit of ₹32.20 crore. The results include a ₹1.87 crore impact from the implementation of New Labour Codes.
Key Highlights
Standalone Revenue from Operations rose 33.5% YoY to ₹312.67 crore in Q3 FY26.
Net Profit for the quarter surged 183% YoY to ₹6.68 crore from ₹2.36 crore.
Basic EPS for the quarter improved significantly to ₹5.07 from ₹1.93 YoY.
9-month FY26 Net Profit of ₹32.20 crore has already exceeded the full FY25 profit of ₹21.15 crore.
Employee benefit expenses include a ₹1.87 crore impact due to New Labour Code implementation.
👀 What to Watch
The company is demonstrating strong growth momentum with 9-month profits already exceeding the previous full year's performance. Investors should maintain a positive outlook while monitoring the impact of rising material costs and labor code changes on operating margins.
SBI to Seek Shareholder Approval for Related Party Transactions Exceeding ₹5,000 Crore
State Bank of India (SBI) has called for an Extraordinary General Meeting (EGM) on March 27, 2026, to seek shareholder approval for material related party transactions for FY 2026-27. The bank expects transactions with subsidiaries like SBI Life and SBI Cards to exceed the materiality threshold of ₹5,000 crore or 10% of annual consolidated turnover. These transactions include distribution commissions, investment in debt securities, and various banking services. The move is a regulatory requirement to ensure transparency in intra-group dealings and will be conducted on an arm's length basis.
Key Highlights
EGM scheduled for March 27, 2026, to approve transactions for the financial year 2026-27.
Materiality threshold for transactions set at ₹5,000 crore or 10% of annual consolidated turnover.
Major related parties include SBI Life Insurance, SBI Cards, SBI Payment Services, and Yes Bank.
Transactions cover distribution commissions, repo/reverse repo, and purchase/sale of government securities.
All proposed arrangements are mandated to be carried out on an arm's length basis per SEBI regulations.
👀 What to Watch
This is a routine regulatory compliance procedure for a large banking conglomerate; investors should view this as standard corporate governance with no immediate impact on stock valuation.
ESAB India Declares Second Interim Dividend of Rs 25 Per Share; Record Date Feb 14
ESAB India Limited has declared a second interim dividend of Rs 25 per equity share for the financial year 2025-26, representing a 250% payout on its face value of Rs 10. The total financial outflow for this dividend distribution is estimated at Rs 38.48 crore. The company has fixed February 14, 2026, as the record date to determine eligible shareholders. The dividend is scheduled to be paid to shareholders on or before March 6, 2026.
Key Highlights
Second interim dividend of Rs 25 per equity share (250% of face value) declared.
Total dividend payout amounts to Rs 38,48,25,500 for the financial year 2025-26.
Record date for eligibility is February 14, 2026.
Payment to be completed on or before March 6, 2026.
👀 What to Watch
Investors interested in the dividend should ensure they hold the shares before the ex-dividend date to be eligible for the Rs 25 per share payout. The substantial dividend reflects the company's healthy cash flow and commitment to shareholder returns.
ESAB India Declares ₹25 Interim Dividend; Q3 PAT Rises 6.5% to ₹43 Crore
ESAB India has declared a second interim dividend of ₹25 per share for FY 2025-26, with the record date set for February 14, 2026. For the quarter ended December 31, 2025, the company reported a total income of ₹379.9 crore, representing an 11.5% growth over the previous year. Net profit for the quarter rose to ₹43 crore from ₹40.4 crore, despite a one-time exceptional expense of ₹13.65 crore related to new labour code provisions. The company's 9-month performance remains robust with a PAT of ₹163.1 crore compared to ₹128 crore in the prior year period.
Key Highlights
Declared second interim dividend of ₹25 per share (250%) with a record date of February 14, 2026.
Quarterly revenue from operations increased 11.5% YoY to ₹379.9 crore.
Net Profit (PAT) for Q3 grew to ₹43 crore, overcoming a ₹13.65 crore exceptional charge for gratuity liabilities.
9-month EPS surged to ₹106.01 compared to ₹83.16 in the corresponding period last year.
Total dividend outflow for this interim declaration is approximately ₹38.48 crore.
👀 What to Watch
Investors should note the upcoming record date of February 14 to be eligible for the ₹25 dividend. The company continues to demonstrate steady operational growth and a strong dividend payout policy, making it attractive for long-term portfolios.
ESAB India Q3 Net Profit Up 6.5% YoY to ₹43 Cr; Declares ₹25 Interim Dividend
ESAB India reported a steady performance for Q3 FY26 with a 6.5% YoY increase in net profit to ₹43 crore. Total income grew 11.5% YoY to ₹379.9 crore, driven by its core fabrication technology segment. The company declared a second interim dividend of ₹25 per share, bringing the total interim dividend for the year to ₹50. Profits were slightly tempered by a one-time exceptional charge of ₹13.65 crore related to gratuity liability adjustments under the new Code on Wages.
Key Highlights
Total income for Q3 FY26 rose 11.5% YoY to ₹379.9 crore from ₹340.8 crore.
Net Profit after Tax stood at ₹43 crore, up from ₹40.4 crore in the same quarter last year.
Declared a second interim dividend of ₹25 per equity share for the financial year 2025-26.
Recognized an exceptional loss of ₹13.65 crore due to increased gratuity liability from the Code on Wages 2019.
9M FY26 Net Profit reached ₹163.1 crore, a 27.5% increase over the ₹128 crore reported in 9M FY25.
👀 What to Watch
Investors should remain positive as the company demonstrates consistent revenue growth and a strong commitment to shareholder returns through dividends. The exceptional hit is a non-recurring regulatory adjustment and does not impact the core operational efficiency.
Triveni Turbine Q3 Revenue Up 24% to ₹6.24 Billion; PAT Dips 1% on Exceptional Charge
Triveni Turbine reported a strong 24% YoY revenue growth in Q3 FY26, reaching ₹6.24 billion, though PAT slightly declined by 1% to ₹917 million due to a ₹15.7 crore non-recurring wage code charge. While order bookings for the quarter fell 26% YoY due to timing issues with advances, the company maintains a robust domestic enquiry pipeline across steel, cement, and sugar sectors. The US subsidiary reported a loss of ₹21.7 crore for the nine-month period, but management expects a recovery in Q4 and FY27 driven by new products like heat pumps and MVRs.
Key Highlights
Q3 FY26 Revenue grew 24% YoY to ₹6.24 billion, while EBITDA rose 16.9% to ₹1.54 billion.
Order booking for Q3 declined 26% YoY, primarily due to delayed advances on pending orders at quarter-end.
US subsidiary recorded a loss of ₹21.7 crore in the first nine months of FY26.
Management expects double-digit growth in domestic order bookings in Q4 FY26 driven by steel and cement sectors.
First order received for CO2-based heat pumps with an enquiry pipeline currently exceeding 100 units.
👀 What to Watch
Investors should monitor the conversion of the strong enquiry pipeline into firm orders in Q4 to validate management's growth guidance. The reduction in US duty to 18% and traction in new product segments like heat pumps are positive long-term catalysts despite short-term subsidiary losses.
IFB Industries Q3 FY26: Revenue Up 12% to ₹1,382 Cr, PAT Impacted by Forex and Labor Costs
IFB Industries reported a 12% YoY revenue growth to ₹1,382 crores for Q3 FY26, though PAT declined to ₹24.51 crores from ₹34.36 crores last year. Earnings were pressured by a ₹13.38 crore exceptional charge related to the new Labour Code and significant margin headwinds from forex depreciation and commodity price hikes. Despite these pressures, the company maintained a strong 25%+ market share in front-load washing machines and is targeting ₹79 crores in material cost savings for the full year through efficiency initiatives.
Key Highlights
Q3 Revenue grew 12% YoY to ₹1,382 crores, while PBDIT margins contracted from 7.3% to 5.8%.
Forex losses of ₹29 crores and commodity hikes of ₹18 crores YTD largely offset ₹35 crores in cost innovation savings.
Recognized an exceptional liability of ₹13.38 crores following the Government of India's Labour Code notification.
Front-load washing machine market share remains robust at 25%+, with peak capacity utilization reaching 88-90%.
Projected full-year material cost reduction of ₹79 crores via the A&M efficiency program, with ₹35 crores realized YTD.
👀 What to Watch
Investors should monitor the company's ability to recover margins as efficiency projects scale and commodity prices stabilize. While market share in core segments remains strong, the impact of the new Labour Code and forex volatility are key risks to watch in the upcoming quarter.
Ambika Cotton Mills to Expand Capacity to 120,816 Spindles with ₹57 Cr Investment
Ambika Cotton Mills has successfully commissioned 6,048 spindles for specialty yarn and announced a further addition of 6,480 spindles by May 2026. This total expansion of 12,528 spindles will increase the company's total capacity to 120,816 spindles. The project includes solar capacity for captive consumption to manage energy costs. The total investment of ₹57.00 Crores will be funded entirely through internal accruals, reflecting a strong debt-free growth strategy.
Key Highlights
Commissioned 6,048 spindles for specialty yarn production at Dindigul, Tamil Nadu
Proposed addition of 6,480 spindles scheduled for commissioning in May 2026
Total spindle capacity to reach 120,816 units following the expansion
Estimated project cost of ₹57.00 Crores includes solar power for captive use
Funding to be met entirely through internal accruals, maintaining a healthy balance sheet
👀 What to Watch
Investors should view this as a positive development as the company is expanding its high-margin specialty yarn capacity without taking on debt. Monitor the progress of the May 2026 commissioning for timely execution.
